P1455: FIRST-IN-HUMAN TRIAL OF CB-010, A CRISPR-EDITED ALLOGENEIC ANTI-CD19 CAR -T CELL THERAPY WITH A PD-1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON-HODGKIN LYMPHOMA (ANTLER STUDY)
暂无分享,去创建一个
S. Kanner | J. Essell | J. Skoble | L. Nastoupil | H. Holmes | L. Dsouza | E. Matsuda | D. Hart | E. Garner | S. O'Brien | T. Satterfield-Ledbetter | M. Bryan | E. Li | C. T. Thomas